Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis

A Scleroderma Patient-Centered Intervention Network Cohort Study

SPIN Investigators

Research output: Contribution to journalArticle

Abstract

Objective: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8-item versions (BFNE-S, BFNE-8) and one 12-item version (BFNE-II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. Methods: Participants were 1,010 patients with SSc enrolled in the Scleroderma Patient-Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product-moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. Results: Confirmatory factor analysis demonstrated that 1-factor models fit acceptably well for the 12-item BFNE-II, the 8-item BFNE-S, and the 8-item BFNE-8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE-II = 0.98, BFNE-S = 0.97, BFNE-8 = 0.96), and all versions had comparable associations with measures of social anxiety, body-related attitudes, depression, age, and education. Conclusion: Psychometric support was found for all 3 versions of the BFNE, although the longer 12-item BFNE-II did not improve measurement compared to the shorter 8-item versions (BFNE-S and BFNE-8). Of these 2, the BFNE-S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE-S is recommended to assess fear of negative evaluation among patients with SSc.

Original languageEnglish (US)
Pages (from-to)1646-1652
Number of pages7
JournalArthritis Care and Research
Volume70
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Systemic Scleroderma
Reproducibility of Results
Fear
Cohort Studies
Statistical Factor Analysis

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{d28461b3b74b404b863326495471e1ed,
title = "Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study",
abstract = "Objective: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8-item versions (BFNE-S, BFNE-8) and one 12-item version (BFNE-II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. Methods: Participants were 1,010 patients with SSc enrolled in the Scleroderma Patient-Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product-moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. Results: Confirmatory factor analysis demonstrated that 1-factor models fit acceptably well for the 12-item BFNE-II, the 8-item BFNE-S, and the 8-item BFNE-8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE-II = 0.98, BFNE-S = 0.97, BFNE-8 = 0.96), and all versions had comparable associations with measures of social anxiety, body-related attitudes, depression, age, and education. Conclusion: Psychometric support was found for all 3 versions of the BFNE, although the longer 12-item BFNE-II did not improve measurement compared to the shorter 8-item versions (BFNE-S and BFNE-8). Of these 2, the BFNE-S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE-S is recommended to assess fear of negative evaluation among patients with SSc.",
author = "{SPIN Investigators} and Fox, {Rina S.} and Linda Kwakkenbos and Carrier, {Marie Eve} and Mills, {Sarah D.} and Shadi Gholizadeh and Jewett, {Lisa R.} and Roesch, {Scott C.} and Merz, {Erin L.} and Shervin Assassi and Furst, {Daniel E.} and Karen Gottesman and Mayes, {Maureen D.} and Thombs, {Brett D.} and Malcarne, {Vanessa L.} and Murray Baron and Bartlett, {Susan J.} and Carolyn Ells and Marie Hudson and Yeona Jang and Annett K{\"o}rner and Suzanne Kafaja and {van den Hoogen}, Frank and Shervin Assassi and Luc Mouthon and Nielson, {Warren R.} and Robert Riggs and Karen Nielsen and Fredrick Wigley and Isabelle Boutron and Maia, {Angela Costa} and Catarina Leite and Ghassan El-Baalbaki and {van den Ende}, Cornelia and Kim Fligelstone and Tracy Frech and Dominique Godard and Daphna Harel and Ann Impens and Johnson, {Sindhu R.} and Kennedy, {Ann Tyrell} and Nader Khalidi and Carlo Marra and Janet Pope and Alexandra Portales and David Luna and Schouffoer, {Anne A.} and Brooke Levis and Suarez-Almazor, {Maria E.} and Joep Welling and Durhane Wong-Rieger",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/acr.23532",
language = "English (US)",
volume = "70",
pages = "1646--1652",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis

T2 - A Scleroderma Patient-Centered Intervention Network Cohort Study

AU - SPIN Investigators

AU - Fox, Rina S.

AU - Kwakkenbos, Linda

AU - Carrier, Marie Eve

AU - Mills, Sarah D.

AU - Gholizadeh, Shadi

AU - Jewett, Lisa R.

AU - Roesch, Scott C.

AU - Merz, Erin L.

AU - Assassi, Shervin

AU - Furst, Daniel E.

AU - Gottesman, Karen

AU - Mayes, Maureen D.

AU - Thombs, Brett D.

AU - Malcarne, Vanessa L.

AU - Baron, Murray

AU - Bartlett, Susan J.

AU - Ells, Carolyn

AU - Hudson, Marie

AU - Jang, Yeona

AU - Körner, Annett

AU - Kafaja, Suzanne

AU - van den Hoogen, Frank

AU - Assassi, Shervin

AU - Mouthon, Luc

AU - Nielson, Warren R.

AU - Riggs, Robert

AU - Nielsen, Karen

AU - Wigley, Fredrick

AU - Boutron, Isabelle

AU - Maia, Angela Costa

AU - Leite, Catarina

AU - El-Baalbaki, Ghassan

AU - van den Ende, Cornelia

AU - Fligelstone, Kim

AU - Frech, Tracy

AU - Godard, Dominique

AU - Harel, Daphna

AU - Impens, Ann

AU - Johnson, Sindhu R.

AU - Kennedy, Ann Tyrell

AU - Khalidi, Nader

AU - Marra, Carlo

AU - Pope, Janet

AU - Portales, Alexandra

AU - Luna, David

AU - Schouffoer, Anne A.

AU - Levis, Brooke

AU - Suarez-Almazor, Maria E.

AU - Welling, Joep

AU - Wong-Rieger, Durhane

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Objective: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8-item versions (BFNE-S, BFNE-8) and one 12-item version (BFNE-II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. Methods: Participants were 1,010 patients with SSc enrolled in the Scleroderma Patient-Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product-moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. Results: Confirmatory factor analysis demonstrated that 1-factor models fit acceptably well for the 12-item BFNE-II, the 8-item BFNE-S, and the 8-item BFNE-8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE-II = 0.98, BFNE-S = 0.97, BFNE-8 = 0.96), and all versions had comparable associations with measures of social anxiety, body-related attitudes, depression, age, and education. Conclusion: Psychometric support was found for all 3 versions of the BFNE, although the longer 12-item BFNE-II did not improve measurement compared to the shorter 8-item versions (BFNE-S and BFNE-8). Of these 2, the BFNE-S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE-S is recommended to assess fear of negative evaluation among patients with SSc.

AB - Objective: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8-item versions (BFNE-S, BFNE-8) and one 12-item version (BFNE-II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. Methods: Participants were 1,010 patients with SSc enrolled in the Scleroderma Patient-Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product-moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. Results: Confirmatory factor analysis demonstrated that 1-factor models fit acceptably well for the 12-item BFNE-II, the 8-item BFNE-S, and the 8-item BFNE-8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE-II = 0.98, BFNE-S = 0.97, BFNE-8 = 0.96), and all versions had comparable associations with measures of social anxiety, body-related attitudes, depression, age, and education. Conclusion: Psychometric support was found for all 3 versions of the BFNE, although the longer 12-item BFNE-II did not improve measurement compared to the shorter 8-item versions (BFNE-S and BFNE-8). Of these 2, the BFNE-S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE-S is recommended to assess fear of negative evaluation among patients with SSc.

UR - http://www.scopus.com/inward/record.url?scp=85055458173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055458173&partnerID=8YFLogxK

U2 - 10.1002/acr.23532

DO - 10.1002/acr.23532

M3 - Article

VL - 70

SP - 1646

EP - 1652

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 11

ER -